Tapped as Kymab CEO, Si­mon Sturge jumps back in­to biotech pond as Dave Chiswell steps aside

Dave Chiswell is wind­ing down a leg­endary ca­reer — mark­ing a run as Cam­bridge An­ti­body Tech­nol­o­gy’s co-founder and, lat­er, CEO — by mov­ing to the back­seat at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.